Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?

Objective: To assess differences in anal cancer incidence between racial/ethnic groups among a clinical cohort of men with HIV who have sex with men. Design: Clinical cohort study Methods: We studied men who have sex with men (MSM) in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) who initiated antiretroviral therapy (ART) under HIV care in CNICS. We compared anal cancer incidence between Black and non-Black men and calculated hazard ratios controlling for demographic characteristics (age, CNICS site, year of ART initiation), HIV disease indicators (nadir CD4+, peak HIV RNA), and co-infection/behavioral factors including hepatitis B virus (HBV), hepatitis C virus (HCV), tobacco smoking and alcohol abuse. Results: We studied 7473 MSM with HIV who contributed 41 810 person-years of follow-up after initiating ART between 1996 and 2014 in CNICS. Forty-one individuals had an incident diagnosis of anal cancer under observation. Crude rates of anal cancer were 204 versus 61 per 100 000 person-years among Black versus non-Black MSM. The weighted hazard ratio for anal cancer in Black MSM (adjusting for demographics, HIV disease factors, and co-infection/behavioral factors) was 2.37 (95% confidence interval: 1.17, 4.82) compared to non-Black MSM. Conclusions: In this large multicenter cohort, Black MSM were at significantly increased risk for anal cancer compared to non-Black MSM. Further detailed studies evaluating factors impacting anal cancer incidence and outcomes in Black men with HIV are necessary. Inclusion of more diverse study cohorts may elucidate modifiable factors associated with increased anal cancer risk experienced by Black MSM.

[1]  P. Bonfanti,et al.  HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation , 2021, HIV medicine.

[2]  V. Nfonsam,et al.  Racial and gender disparities in the incidence of anal cancer: analysis of the Nationwide Inpatient Sample (NIS). , 2018, Journal of gastrointestinal oncology.

[3]  G. Clifford,et al.  Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis , 2018, The Journal of infectious diseases.

[4]  L. Siproudhis,et al.  Determinants of high-grade anal intraepithelial lesions in HIV-positive MSM , 2018, AIDS.

[5]  A. Giuliano,et al.  Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in a Sample of Young, Predominantly Black Men Who Have Sex With Men, Houston, Texas , 2018, The Journal of infectious diseases.

[6]  E. Cachay,et al.  Disparities in the Clinical Evolution of Anal Neoplasia in an HIV-Infected Cohort , 2018, Journal of Racial and Ethnic Health Disparities.

[7]  S. Franceschi,et al.  Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis , 2017, The Lancet. Infectious diseases.

[8]  H. D. de Vries,et al.  Risk factors for anal high-grade squamous intraepithelial lesions in HIV-positive MSM: is targeted screening possible? , 2017, AIDS.

[9]  J. Raboud,et al.  Progression From Perianal High-Grade Anal Intraepithelial Neoplasia to Anal Cancer in HIV-Positive Men Who Have Sex With Men , 2016, Diseases of the colon and rectum.

[10]  Richard D Moore,et al.  Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. , 2015, Annals of internal medicine.

[11]  R. Pfeiffer,et al.  Excess cancers among HIV-infected people in the United States. , 2015, Journal of the National Cancer Institute.

[12]  J. Schneider,et al.  Systematic review of racial disparities in human papillomavirus-associated anal dysplasia and anal cancer among men who have sex with men. , 2015, American journal of public health.

[13]  R. Pfeiffer,et al.  Age at cancer diagnosis for blacks compared with whites in the United States. , 2015, Journal of the National Cancer Institute.

[14]  A. Jemal,et al.  Trends in the occurrence of high‐grade anal intraepithelial neoplasia in San Francisco: 2000‐2009 , 2013, Cancer.

[15]  S. Franceschi,et al.  Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. , 2013, American journal of epidemiology.

[16]  Richard D Moore,et al.  Incidence and timing of cancer in HIV-infected individuals following initiation of combination antiretroviral therapy. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  H. El‐Serag,et al.  The Impact of HIV Viral Control on the Incidence of HIV-Associated Anal Cancer , 2013, Journal of acquired immune deficiency syndromes.

[18]  J. Palefsky,et al.  Risk Factors for Anal Human Papillomavirus Infection Type 16 Among HIV-Positive Men Who Have Sex With Men in San Francisco , 2013, Journal of acquired immune deficiency syndromes.

[19]  R. Pfeiffer,et al.  Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. , 2012, Journal of the National Cancer Institute.

[20]  Richard D Moore,et al.  Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  S. Cole,et al.  Splines for trend analysis and continuous confounder control. , 2011, Epidemiology.

[22]  J. Goedert,et al.  Cancer burden in the HIV-infected population in the United States. , 2011, Journal of the National Cancer Institute.

[23]  S. Cole,et al.  Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy , 2011, AIDS.

[24]  A. Mocroft,et al.  Relationship between current level of immunodeficiency and non‐acquired immunodeficiency syndrome‐defining malignancies , 2010, Cancer.

[25]  C. Compton,et al.  The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.

[26]  A. Justice,et al.  Incidence of Non-AIDS-Defining Malignancies in HIV-Infected Versus Noninfected Patients in the HAART Era: Impact of Immunosuppression , 2009, Journal of acquired immune deficiency syndromes.

[27]  C. Ko,et al.  Outcomes and Prognostic Factors for Squamous-Cell Carcinoma of the Anal Canal: Analysis of Patients From the National Cancer Data Base , 2009, Diseases of the colon and rectum.

[28]  Richard D Moore,et al.  Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. , 2008, International journal of epidemiology.

[29]  Ross D. Cranston,et al.  Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study , 2008, Journal of acquired immune deficiency syndromes.

[30]  M. Falster,et al.  Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.

[31]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[32]  J. Palefsky,et al.  Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. , 1994, Journal of acquired immune deficiency syndromes.

[33]  Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV , 2020 .

[34]  R. Pfeiffer,et al.  Anal Cancer Risk Among People With HIV Infection in the United States. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  E. Engels,et al.  Evolving epidemiology of HIV-associated malignancies , 2017, Current opinion in HIV and AIDS.

[36]  J. Gallant,et al.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.